Cardiac allograft vasculopathy and acute rejection surveillance in the same procedure through a single vascular access. High volume center experienceCarlos Arellano Serrano, Francisco José Hernández Pérez, Javier Goicolea Ruigómez et al.|European Heart Journal|2021Cited by 1
Potential Role of Donor-Derived Cell Free DNA as a New Biomarker in Cardiac Allograft Vasculopathy (FreeDNA-CAV)Marta Jiménez-Blanco Bravo, Lalita Gomez, Carlos Arellano Serrano et al.|The Journal of Heart and Lung Transplantation|2020Cited by 0
TCT CONNECT-461 Predictors of Reversibility of Left Bundle Branch Block After TAVI ImplantationCarlos Arellano Serrano, J. Domínguez, Sara Lozano Jiménez et al.|Journal of the American College of Cardiology|2020Cited by 0
6108-7. BIOPSIA ENDOMIOCÁRDICA EN AMILOIDOSIS CARDIACA: EXPERIENCIA EN UN CENTRO DE REFERENCIACarlos Arellano Serrano, Javier Segovia Cubero, Juan Francisco Oteo Domínguez et al.|Revista Española de Cardiología|2025Cited by 0